Alpha Medical Acquires the Leading Provider of Genetic Examinations in Slovakia

July 3, 2014
Image 3 - white

Alpha Medical, the leading medical laboratory services provider in Slovakia and the Czech Republic controlled by MidEuropa, announced today that it has completed the acquisition of Gendiagnostica, the leading provider of genetic testing in Slovakia. This transaction marks a further step in Mid Europa’s strategy to consolidate the Central European medical laboratory market and to complement the service offering of Alpha Medical to its clients. Earlier in June, Mid Europa announced the acquisition of Euromedic Labs in the Czech Republic.

Gendiagnostica is the leading provider of genetic testing in Slovakia, one of the most innovative and promising diagnostics methods based on the genetic detection of cardiovascular and cancer risks as well as hereditary diseases and other pathologies.


Matthew Strassberg, Senior Partner of MidEuropa who leads the healthcare investments said:

“The acquisition of Gendiagnostica further strengthens Alpha Medical’s market leadership position in Slovakia. It is consistent with our strategy to expand the service offering of our Central European laboratory platform to include specialized tests such as genetics and pathology, furnishing both doctors and patients with more accurate diagnoses, and improved therapy selection in areas such as cancer treatment, cardiovascular treatment and pre-natal testing.”


Peter Lednicky, the CEO of Alpha Medical said:

“We are very pleased to have completed the acquisition of Gendiagnostica and strongly believe that the combination of the long-standing experience of Alpha Medical and Gendiagnostica will contribute to the development and popularization of cutting-edge laboratory services in Slovakia and accelerated growth of both businesses.”


Pawel Padusinski, Jan Krzewinski and Artur Sienczewski supported Alpha Medical’s management team in executing the transaction.